Evidence map›Paper›PMID 25069832›Full record

ArticleBreast cancer research : BCR2014

MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.

Raisa Krutilina, Wenlin Sun, Aarti Sethuraman, Martin Brown, Tiffany N Seagroves, Lawrence M Pfeffer, Tatyana Ignatova, Meiyun Fan

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 102 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Hypoxia-driven ncRNAs in breast cancer.Frontiers in oncology · 2023
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Raisa KrutilinaDepartments of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, 19 South Manassas Street, Memphis, TN, 38163, USA. rkrutili@uthsc.edu.
Wenlin SunDepartment of Pharmacology, University of Tennessee Health Science Center, 424 Crowe research building, 874 Union Avenue, Memphis, TN, 38163, USA. wsun5@uthsc.edu.
Aarti SethuramanDepartments of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, 19 South Manassas Street, Memphis, TN, 38163, USA. asethur1@uthsc.edu.
Martin BrownCenter for Cancer Research, University of Tennessee Health Science Center, 19 South Manassas Street, Memphis, TN, 38163, USA. martinmbrown@gmail.com.
Tiffany N SeagrovesDepartments of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, 19 South Manassas Street, Memphis, TN, 38163, USA. tseagro1@uthsc.edu.
Lawrence M PfefferDepartments of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, 19 South Manassas Street, Memphis, TN, 38163, USA. lpfeffer@uthsc.edu.
Tatyana IgnatovaDepartment of Neurosurgery, University of Tennessee Health Science Center, 847 Monroe Avenue, Memphis, TN, 38163, USA. tnignatova@yahoo.com.
Meiyun FanDepartments of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, 19 South Manassas Street, Memphis, TN, 38163, USA. mfan2@uthsc.edu.
University of Tennessee Health Science Center · USCenter for Cancer Research · US

Funding

The Role of HIF-1alpha in Breast Cancer Stem Cell ActivityR01CA138488 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI SEAGROVES, TIFFANY NICOLE · 2010 to 2014
$1.5M
Molecular mechanism of ID1 function in advanced breast cancerR01CA140346 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI FAN, MEIYUN · 2009 to 2013
$1.2M
NCI NIH HHS CA138488NCI NIH HHS CA140346NCI NIH HHS R01 CA138488NCI NIH HHS R01 CA140346
6 · The paper itself

Abstract

introductionIn breast cancer, distinct expression profiles of microRNAs (miRNAs) have been associated with molecular subgroups and clinicopathological characteristics, implicating a diagnostic and prognostic role of miRNAs. However, the biological functions of deregulated miRNAs in tumor progression are not yet completely defined. In this study, we investigated the function of miR-18a in regulating breast cancer metastasis through the hypoxia-inducible factor 1α (HIF1A)-dependent hypoxic response.

methodsAn orthotopic metastatic breast cancer xenograft model (MDA-MB-231 cells) was used to identify miRNAs associated with spontaneous lung metastasis. The function of miR-18a in regulating HIF1A expression, as well as cellular responses to hypoxia and metastasis, were then studied in vitro and in vivo by assessing ectopic miR-18a expression or miR-18a inhibition. miRNA-mRNA interactions (AGO2 immunoprecipitation and 3' untranslated region Luciferase reporter assays), gene expression (quantitative PCR and microarray), cell migration and invasion, and cell growth were assessed under normoxic or hypoxic conditions, complemented by orthotopic xenograft of tumor cells to the mammary fat pad to investigate the effect of modulating miR-18a expression on primary tumor growth and lung metastasis. Last, clinically relevant correlations between miR-18a, HIF1A, hypoxia-responsive gene expression and distant metastasis-free survival (DMFS) were assessed using published expression array breast tumors data sets.

resultsmiRNAs encoded by the MIR17HG gene were downregulated in lung metastases compared to primary tumors. Ectopic expression of miR-18a, a MIR17HG family member, in a metastatic variant of MDA-MB-231 cells reduced primary tumor growth and lung metastasis, whereas miR-18a inhibition in the parental cells promoted tumor growth and lung metastasis. We identified HIF1A as a direct target of miR-18a. Modulating miR-18a expression significantly affected hypoxic gene expression, cell invasiveness and sensitivity to anoikis and hypoxia in vitro in a HIF1A-dependent manner. Analysis of previously published data revealed that higher expression of HIF1A and a panel of hypoxic genes is associated with shorter DMFS interval in patients with basal-like breast tumors, and that, within this subtype, miR-18a expression is inversely correlated with hypoxic gene expression. Together, these data support a role of miR-18a in repressing distant metastasis through a HIF1A-dependent pathway.

conclusionsThe results of this study reveal a novel role for miR-18a in targeting HIF1A and repressing metastasis of basal-like breast tumors.

Indexed as

AnimalsBreast NeoplasmsCell HypoxiaFemaleGene Expression Regulation, NeoplasticHumansHypoxia-Inducible Factor 1, alpha SubunitLung NeoplasmsMCF-7 CellsMice, Inbred NODMice, SCIDMicroRNAsNeoplasms, Basal CellRNA InterferenceHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitMicroRNAsMIRN18A microRNA, human

Identifiers

PMID25069832
PMCPMC4405876
OpenAlexW2142819472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.